Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Foundayo (orforglipron) is Eli Lilly's oral GLP-1 medication for chronic weight management, FDA-approved on April 1, 2026
People taking once-daily elecoglipron lost up to 11.8% of their body weight over a 36-week period, the data showed
Research has also examined its potential roles in modulating gene expression associated with extracellular matrix remodelling
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
When you're ready to conduct serious research, we're ready to be your trusted partner
US$ 23.17
US$ 20.01
US$ 28.95
US$ 22.28
US$ 27.54
US$ 21.16
US$ 21.52
